In last trading session, Prelude Therapeutics Inc (NASDAQ:PRLD) saw 0.24 million shares changing hands with its beta currently measuring 1.38. Company’s recent per share price
During the last session, Prelude Therapeutics Inc (NASDAQ:PRLD)’s traded shares were 0.46 million, with the beta value of the company hitting 1.38. At the end
Prelude Therapeutics Inc (NASDAQ:PRLD)’s traded shares stood at 0.44 million during the last session, with the company’s beta value hitting 1.44. At the close of
In the last trading session, 1.43 million Prelude Therapeutics Inc (NASDAQ:PRLD) shares changed hands as the company’s beta touched 1.40. With the company’s per share
In the latest trading session, 0.95 million Prelude Therapeutics Inc (NASDAQ:PRLD) shares changed hands as the company’s beta touched 1.40. With the company’s most recent
During the last session, Prelude Therapeutics Inc (NASDAQ:PRLD)’s traded shares were 0.45 million, with the beta value of the company hitting 1.49. At the end
In today’s recent session, 0.65 million shares of the Prelude Therapeutics Inc (NASDAQ:PRLD) have been traded, and its beta is 1.48. Most recently the company’s
Prelude Therapeutics Inc (NASDAQ:PRLD)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.48. At the close of
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
